Problem statement: Answer the MCQ question.
Question: Which drug exhibits a -45.877% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) CCN(CC)c1nc2ccccc2[nH]c1=O
(b) Cc1sc2nc(COC(=O)c3ccc(N4CCCC4)c([N+](=O)[O-])c3)[nH]c(=O)c2c1C
(c) C=CCNC(=O)/C(=C/c1ccc(Br)cc1)NC(=O)c1ccccc1OC
Answer: c. C=CCNC(=O)/C(=C/c1ccc(Br)cc1)NC(=O)c1ccccc1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C=CCNC(=O)/C(=C/c1ccc(Br)cc1)NC(=O)c1ccccc1OC
C=CCNC(=O)/C(=C/c1ccc(Br)cc1)NC(=O)c1ccccc1OC
N-[(Z)-1-(4-bromophenyl)-3-oxo-3-(prop-2-enylamino)prop-1-en-2-yl]-2-methoxybenzamide